Literature DB >> 30586161

Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives.

Aimee C Hodowanec1, Andreas Pikis1, Takashi E Komatsu1, Mario R Sampson2, Islam R Younis2, Julian J O'Rear1, Mary E Singer1.   

Abstract

This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV prevention and treatment strategies is provided, including a detailed description of each of the available CMV antiviral drugs.
© 2018, The American College of Clinical Pharmacology.

Entities:  

Keywords:  antiviral drugs; cytomegalovirus; immunocompromised; infectious diseases; transplantation; viral diseases

Mesh：

Substances：

Year:  2018        PMID： 30586161     DOI： 10.1002/jcph.1363

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


  2 in total

Review 1.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

2.  The Performance of Metagenomic Next-Generation Sequence in the Diagnosis of Suspected Opportunistic Infections in Patients with Acquired Immunodeficiency Syndrome.

Authors:  Li Liu; Mingjuan Yuan; Siqing Sun; Jinrong Wang; Yi Shi; Yamin Yu; Xin Su
Journal:  Infect Drug Resist       Date:  2022-09-24       Impact factor: 4.177
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.